Bond.az – Moderna shares rose 13% after reports of a Hantavirus outbreak on the MV Hondius cruise ship.
Bernstein Global Research downplays the risk of a widespread pandemic, calling the rally short-lived.
Bernstein reiterated its Market-Perform rating on Moderna with a $45 price target.
The Andes strain infected about 10 people, with three fatalities.
Human-to-human transmission is possible, with a 30-40% mortality rate.
Analysts say a global crisis is highly unlikely.
